Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 32


Neutrophil Elastase-mediated proteolysis activates the anti-inflammatory cytokine IL-36 Receptor antagonist.

Macleod T, Doble R, McGonagle D, Wasson CW, Alase A, Stacey M, Wittmann M.

Sci Rep. 2016 Apr 22;6:24880. doi: 10.1038/srep24880.


Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease.

Boutet MA, Bart G, Penhoat M, Amiaud J, Brulin B, Charrier C, Morel F, Lecron JC, Rolli-Derkinderen M, Bourreille A, Vigne S, Gabay C, Palmer G, Le Goff B, Blanchard F.

Clin Exp Immunol. 2016 May;184(2):159-73. doi: 10.1111/cei.12761. Epub 2016 Feb 22.


Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.

Tsurutani N, Mittal P, St Rose MC, Ngoi SM, Svedova J, Menoret A, Treadway FB, Laubenbacher R, Suárez-Ramírez JE, Cauley LS, Adler AJ, Vella AT.

J Immunol. 2016 Jan 1;196(1):124-34. doi: 10.4049/jimmunol.1501217. Epub 2015 Nov 16.


IL-36α: a novel cytokine involved in the catabolic and inflammatory response in chondrocytes.

Conde J, Scotece M, Abella V, Lois A, López V, García-Caballero T, Pino J, Gómez-Reino JJ, Gómez R, Lago F, Gualillo O.

Sci Rep. 2015 Nov 12;5:16674. doi: 10.1038/srep16674.


Interleukin-36γ is expressed by neutrophils and can activate microglia, but has no role in experimental autoimmune encephalomyelitis.

Bozoyan L, Dumas A, Patenaude A, Vallières L.

J Neuroinflammation. 2015 Sep 17;12:173. doi: 10.1186/s12974-015-0392-7.


IL-36γ Transforms the Tumor Microenvironment and Promotes Type 1 Lymphocyte-Mediated Antitumor Immune Responses.

Wang X, Zhao X, Feng C, Weinstein A, Xia R, Wen W, Lv Q, Zuo S, Tang P, Yang X, Chen X, Wang H, Zang S, Stollings L, Denning TL, Jiang J, Fan J, Zhang G, Zhang X, Zhu Y, Storkus W, Lu B.

Cancer Cell. 2015 Sep 14;28(3):296-306. doi: 10.1016/j.ccell.2015.07.014. Epub 2015 Aug 27.


Rescue of CD8+ T cell vaccine memory following sublethal γ irradiation.

McFarland HI, Berkson JD, Lee JP, Elkahloun AG, Mason KP, Rosenberg AS.

Vaccine. 2015 Jul 31;33(32):3865-72. doi: 10.1016/j.vaccine.2015.06.070. Epub 2015 Jun 26.


Limited Contribution of IL-36 versus IL-1 and TNF Pathways in Host Response to Mycobacterial Infection.

Segueni N, Vigne S, Palmer G, Bourigault ML, Olleros ML, Vesin D, Garcia I, Ryffel B, Quesniaux VF, Gabay C.

PLoS One. 2015 May 7;10(5):e0126058. doi: 10.1371/journal.pone.0126058. eCollection 2015.


Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.

Ciccia F, Accardo-Palumbo A, Alessandro R, Alessandri C, Priori R, Guggino G, Raimondo S, Carubbi F, Valesini G, Giacomelli R, Rizzo A, Triolo G.

Clin Exp Immunol. 2015 Aug;181(2):230-8. doi: 10.1111/cei.12644. Epub 2015 Jun 3.


Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN.

Keermann M, Kõks S, Reimann E, Prans E, Abram K, Kingo K.

BMC Genomics. 2015 Apr 19;16:322. doi: 10.1186/s12864-015-1508-2.


Role of IL-38 and its related cytokines in inflammation.

Yuan X, Peng X, Li Y, Li M.

Mediators Inflamm. 2015;2015:807976. doi: 10.1155/2015/807976. Epub 2015 Mar 19. Review.


Characterization of host immunity during persistent vaginal colonization by Group B Streptococcus.

Patras KA, Rösler B, Thoman ML, Doran KS.

Mucosal Immunol. 2015 Nov;8(6):1339-48. doi: 10.1038/mi.2015.23. Epub 2015 Apr 8.


Interleukin-1 family cytokines and their regulatory proteins in normal pregnancy and pre-eclampsia.

Southcombe JH, Redman CW, Sargent IL, Granne I.

Clin Exp Immunol. 2015 Sep;181(3):480-90. doi: 10.1111/cei.12608. Epub 2015 Jun 29.


Application of IL-36 receptor antagonist weakens CCL20 expression and impairs recovery in the late phase of murine acetaminophen-induced liver injury.

Scheiermann P, Bachmann M, Härdle L, Pleli T, Piiper A, Zwissler B, Pfeilschifter J, Mühl H.

Sci Rep. 2015 Feb 17;5:8521. doi: 10.1038/srep08521.


Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis.

Derer A, Groetsch B, Harre U, Böhm C, Towne J, Schett G, Frey S, Hueber AJ.

PLoS One. 2014 Aug 11;9(8):e101954. doi: 10.1371/journal.pone.0101954. eCollection 2014.


Decreased Langerhans cell responses to IL-36γ: altered innate immunity in patients with recurrent respiratory papillomatosis.

DeVoti J, Hatam L, Lucs A, Afzal A, Abramson A, Steinberg B, Bonagura V.

Mol Med. 2014 Aug 28;20:372-80. doi: 10.2119/molmed.2014.00098.


The chicken IL-1 family: evolution in the context of the studied vertebrate lineage.

Gibson MS, Kaiser P, Fife M.

Immunogenetics. 2014 Aug;66(7-8):427-38. doi: 10.1007/s00251-014-0780-7. Epub 2014 May 27. Review.


IL-36 promotes myeloid cell infiltration, activation, and inflammatory activity in skin.

Foster AM, Baliwag J, Chen CS, Guzman AM, Stoll SW, Gudjonsson JE, Ward NL, Johnston A.

J Immunol. 2014 Jun 15;192(12):6053-61. doi: 10.4049/jimmunol.1301481. Epub 2014 May 14.


Reprogramming tumor-infiltrating dendritic cells for CD103+ CD8+ mucosal T-cell differentiation and breast cancer rejection.

Wu TC, Xu K, Banchereau R, Marches F, Yu CI, Martinek J, Anguiano E, Pedroza-Gonzalez A, Snipes GJ, O'Shaughnessy J, Nishimura S, Liu YJ, Pascual V, Banchereau J, Oh S, Palucka K.

Cancer Immunol Res. 2014 May;2(5):487-500. doi: 10.1158/2326-6066.CIR-13-0217. Epub 2014 Mar 4.


Therapeutic use of dendritic cells to promote the extranodal priming of anti-tumor immunity.

Chen L, Fabian KL, Taylor JL, Storkus WJ.

Front Immunol. 2013 Nov 29;4:388. doi: 10.3389/fimmu.2013.00388. Review.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk